CLUAP1 peptides and vaccines including the same

Details for Australian Patent Application No. 2010350389 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nakamura, Yusuke; Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko; Watanabe, Tomohisa

Agent Davies Collison Cave

Pub. Number AU-A-2010350389

PCT Pub. Number WO2011/125139

Priority 61/322,099 08.04.10 US

Filing date 26 October 2010

Wipo publication date 13 October 2011

International Classifications

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 35/00 Antineoplastic agents

C07K 14/705 Peptides having more than 20 amino acids

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/00 Mutation or genetic engineering

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/125139 Priority application(s): WO2011/125139

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010350521-1-cyclopropyl-8-methyl-7-[5-methyl-6- (methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts

2010350317-Grommet for wire harness